Search Results - "G A Melnichenko"

Analysis of Serum Estrogens Using High-Performance Liquid Chromatography–Tandem Mass Spectrometry Coupled to Differential Ion Mobility Spectrometry by Ioutsi, V. A., Panov, Yu. M., Usol’tseva, L. O., Smolin, E. S., Antsupova, M. A., Volchkov, P. Yu, Melnichenko, G. A., Mokrysheva, N. G.

“…A new quantification method is proposed for the determination of serum estrone (E1), estradiol (E2), and estriol (E3) based on high-performance liquid…”
Get full text

Restoration of fertility in a woman with giant prolactinoma in response to cabergoline treatment by Astaf’eva, L I, Sidneva, Y G, Kadashev, B A, Kalinin, P L, Melnichenko, G A, Agadzhanian, S A

“…Summary A 32-year-old woman presented with primary amenorrhoea, prolactin (PRL) level of 154 150 mIU/L and was diagnosed with a giant pituitary adenoma…”
Get full text

The canonical Wnt/β-catenin pathway: From the history of its discovery to clinical application by Grebennikova, T A, Belaya, Zh E, Rozhinskaya, L Ya, Melnichenko, G A

“…The Wnt/β signaling pathway (Wnt-SP) is a phylogenetically ancient mechanism that regulates development and maintains tissue homeostasis through the control of…”
Get full text

Long-term consequences of polycystic ovary syndrome by O R Grigoryan, N S Zhemaite, N N Volevodz, E N Andreeva, G A Melnichenko, I I Dedov

“…Polycystic ovary syndrome (PCOS) is the most common chronic endocrine disease in women. The prevailing complaints at a young age are menstrual irregularities,…”
Get full text

Familial partial lipodystrophy (Dunnigan syndrome) due to LMNA gene mutation: The first description of its clinical case in Russia by Sorkina, E L, Kalashnikova, M F, Melnichenko, G A, Tyulpakov, A N

“…Hereditary lipodystrophies (HLD) are a heterogeneous group of rare diseases characterized by a complete or partial loss of subcutaneous fat and by the…”
Get full text

Shereshevsky-Turner syndrome: Estrogen replacement therapy and cardiovascular risk factors by O A Yevstigneeva, E N Andreeva, O R Grigoryan, N N Volevodz, G A Melnichenko, I I Dedov

“…Aim. To investigate the impact of menopausal hormone therapy (MHT) on the expression of risk factors for cardiovascular events (CVEs) in patients with…”
Get full text

Role of microRNA in oncogenesis of pituitary tumors and their practical significance by Lapshina, A M, Khandaeva, P M, Belaya, Zh E, Rozhinskaya, L Ya, Melnichenko, G A

“…Microribonucleic acids (miRNAs) are a class of noncoding RNAs that regulate posttranscriptional gene expression. These molecules are regulators of cell…”
Get full text

Carbohydrate metabolism in patients with acromegaly and Itsenko—Cushing disease by L V Matchekhina, Zh E Belaya, G A Melnichenko, M V Shestakova

“…The relevance of investigating carbohydrate metabolism (CM) in patients with acromegaly and Itsenko—Cushing disease is attributable to frequent glucose…”
Get full text

Incretin secretion and glucose metabolism in morbidly obese patients in the early and late periods after biliopancreatic diversion by Dedov, I I, Melnichenko, G A, Troshina, E A, Ershova, E V, Mazurina, N V, Ogneva, N A, Yashkov, Yu I, Ilyin, А V

“…To estimate the parameters of glucose metabolism and to assess the secretion of incretins in patients after biliopancreatic diversion (BPD) for morbid obesity…”
Get full text

Effects of endogenous hypercortisolism on bone mRNA and microRNA expression in humans by Belaya, Z. E., Grebennikova, T. A., Melnichenko, G. A., Nikitin, A. G., Solodovnikov, A. G., Brovkina, O. I., Grigoriev, A. U., Rozhinskaya, L. Y., Dedov, I. I.

“…Summary Hypercortisolism in humans suppresses osteoblastogenesis and osteoblast function through the upregulation of Wnt-signaling antagonists (sclerostin,…”
Get full text

What newly brought endocrinology by the past 2022? by Melnichenko, G. A., Shestakova, M. V.

“…In the past year, the Federal Project “Fight against Diabetes” 2023–2030 was developed in detail and submitted in detail and submitted to the Government of the…”
Get full text

Non-classical hormones from the fibroblast growth factor family by Gronskaia, S. A., Rusyaeva, N. V., Belaya, Zh. E., Melnichenko, G. A.

“…Fibroblast growth factors (FGFs) are a group of signaling molecules named for their ability to promote the growth and proliferation of fibroblasts and various…”
Get full text

Corrigendum: A Rare Case of Co-occurrence of Multiple Endocrine Neoplasia Syndrome and Congenital Adrenal Hyperplasia. (Obesity and metabolism. 2024;21(1):79-84. doi: https://doi.org/10.14341/omet13015) by Bondarenko, A. S., Mamedova, E. O., Belaya, Zh. E., Melnichenko, G. A.

“…A corrigendum on "A Rare Case of Co-occurrence of Multiple Endocrine Neoplasia Syndrome and Congenital Adrenal ­Hyperplasia" by Axenia S. Bondarenko, Elizaveta…”
Get full text

A Rare Case of Co-occurrence of Multiple Endocrine Neoplasia Syndrome and Congenital Adrenal Hyperplasia by Bondarenko, A. S., Mamedova, E. O., Belaya, Zh. E., Melnichenko, G. A.

“…Multiple endocrine neoplasia type 1 (MEN1) and congenital adrenal hyperplasia (CAH) are rare monogenic hereditary endocrinopathies with a prevalence of 1–9…”
Get full text

Analysis of the provision of medical care using telemedicine technologies at the endocrinology research centre by Nazarova, A. S., Prikazchikova, S. S., Kalashnikov, V. Y., Melnichenko, G. A., Mokrysheva, N. G.

“…BACKGROUND : In the first months after the pandemic of the COVID-19, the provision of medical care through telemedicine technologies took a leading position,…”
Get full text

Plasma miRNA expression in patients with genetically confirmed multiple endocrine neoplasia type 1 syndrome and its phenocopies by Trukhina, D. A., Mamedova, E. O., Nikitin, A. G., Koshkin, P. A., Belaya, Zh. E., Melnichenko, G. A.

“…BACKGROUND: MEN-1 is a rare autosomal dominant disease caused by mutations in MEN1 gene encoding the menin protein. This syndrome is characterized by the…”
Get full text

Determination of prolactin reference intervals in different age groups by Kolesnikova, G. S., Malysheva, N. M., Zuraeva, Z. T., Nikankina, L. V., Melnichenko, G. A.

“…BACKGROUND : Clinical diagnostic laboratories (CDL) have at their disposal various automated systems for the measurement of biochemical parameters and markers…”
Get full text

Androgenic status in men during COVID-19 by Rozhivanov, R. V., Melnichenko, G. A., Andreeva, E. N., Mokrysheva, N. G.

“…BACKGROUND . COVID-19 is a disease that has a negative systemic effect on the human body, including the male gonads. Therefore, the androgenic status in men…”
Get full text

The course of gout in a patient with Cushing’s disease after successful surgical treatment by Dzeranova, L. K., Eliseev, M. S., Golounina, O. O., Cheremushkina, E. V., Pigarova, E. A., Melnichenko, G. A.

“…Endogenous  hypercortisolism  is a severe endocrine  disease characterized by prolonged  exposure to excessive amounts of glucocorticoid hormones, accompanied…”
Get full text

Discordant parameters of insulin-like growth factor 1 and growth hormone in the diagnosis and monitoring of acromegaly by Sakhnova, E. E., Przhiyalkovskaya, E. G., Belaya, Zh. E., Melnichenko, G. A.

“…Acromegaly is a rare endocrine disorder associated with multiple complications and increased mortality. Timely diagnosis and adequate treatment can bring the…”
Get full text